Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21151252 | 0.94 | ALOX15 (0.35) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL22908169 | 0.94 | ALOX15 (0.35) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21151976 | 0.94 | TSHR (0.36) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL24844555 | 0.93 | MEN1 (0.33) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21477886 | 0.93 | ALOX15 (0.34) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL23965324 | 0.92 | KDM4E (0.34) | ADORA2AADORA1MEN1ALDH1A1KMT2A | |
| SCHEMBL21151078 | 0.92 | PDK2 (0.31) | — | |
| SCHEMBL23965323 | 0.91 | MEN1 (0.35) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL23965332 | 0.90 | KDM4E (0.36) | TSHRL3MBTL1ALDH1A1MAPTHPGD | |
| SCHEMBL27255438 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210143344-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-21 | — | — | US | disclosed |
| US-20200185615-A1 | ORGANIC CHEMICAL COMPOUND, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC COMPONENT | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | OR10J3, OR51E2, LOXL1 | ADORA3 4367/4885ALOX15 373/4885TSHR 2461/4885 |
| US-20200185615-A1 | ORGANIC CHEMICAL COMPOUND, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC COMPONENT | OSTC, ODC1, ORC3 | ADORA3 4349/4885ALOX15 896/4885TSHR 4476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.